New York, NY -- (SBWIRE) -- 01/31/2013 -- Growing Stock Report initiates a Nasdaq Decliner Watch List for the following Stock: Celsion Corp. (NASDAQ:CLSN)
Celsion Corp. (NASDAQ:CLSN) oncology drug development company, engages in the development and commercialization of targeted chemotherapeutic oncology drugs is trading down 84% on disappointing Phase III data on ThermoDox in Primary Liver Cancer, Study did not provide sufficient evidence of clinical effectiveness. The decline in stock price has prompted Growing Stock Report to add Celsion Corp. (NASDAQ:CLSN) to it's Nasdaq Decliner Watch List.
Click Here to find out what The Street and other Investors are saying about Celsion Corp.
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Vipstockreport.com website, for complete risks and disclosures.
Growing Stock Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)